跳至主要内容
临床试验/NCT00795093
NCT00795093已完成不适用

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient

AstraZeneca1 个研究点 分布在 1 个国家目标入组 552 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
552
试验地点
1
主要终点
Quality of life, productivity loss, frequency and severity of GERD symptoms, health care resource use

研究概览

简要总结

The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

研究设计

研究类型
Observational
观察模型
Cohort

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 6 month history of GERD symptoms
  • Treated with unchanged optimized PPI treatment for any GERD indication during a consecutive 4 week period
  • Remaining GERD symptoms despite optimized PPI treatment
  • Able to read and write in US English, and able to comply with study requirements

排除标准

  • Patients that have not experienced any GERD symptom improvement at all during PPI treatment
  • Involvement in the planning or conduct of the study
  • Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months

结局指标

主要结局

Quality of life, productivity loss, frequency and severity of GERD symptoms, health care resource use

时间窗: Collected at enrollment visit and at 3 and 6 month follow-up. (Health care resource use is at enrollment visit collected retrospectively 6 months)

Utility values

时间窗: Collected at enrollment visit and at 6 month follow-up.

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验